The UK Mesothelioma Act continues to wend its way through the legislative process. The most recent action occurred at a committee hearing - specifics are here. Further meetings are planned, but the process seems headed to a near term conclusion.
Google obviously does not bother with serious quality control when it tosses out browsers and other software. However, the errors in Chrome are reaching new lows, as illustrated by the repeated error message that is copied and pasted below:
"Oops! Google Chrome could not find www.prohostbiotech.com
Did you mean: www.prohostbiotech.com"
Superstars of Science. It's a helpful web site full of information about great scientists. It could be useful for litigation, and certainly for homework research for children.
Using a public court to resolve disputes? Confidentiality may be harder to obtain, at least in Delaware Chancery cases. A first of its kind ruling on new Rule 5.1 is out, and on its way up to the Delaware Supreme Court. The chancery court ruling refused most of the parties' requests for secrecy. The story is told in a new post on the Delaware Business Litigation Report.
It's hard to argue with most visual evidence. So, it's compelling to see and read some of the evidence amassed by USGS on disappearing glaciers. Not far away glaciers. Instead, the glaciers in Montana that created Glacier National Park.
During recent years, Dan Fagre and others from USGS publicized the demise of specific glaciers within the park. Now out is a new, comprehensive book documenting the work of Fagre and others, and the broader effects across ecosystems: "The Melting World: A Journey Across America’s Vanishing Glaciers" by Christopher White.
Lung cancer claiming in asbestos litigation is one of the current "hot topics." This week the dialog will continue at Perrin Conference's December 12 asbestos conference in NY. The dialog will be made more useful by a data-filled paper recently published by Marc Scarcella and Peter Kelso of Bates White and Joseph Cagnoli of Segal McCambridge. Among other things, the paper provides a powerful overview of the linkage between the economics of asbestos trust claiming and tort system claiming. The paper is a "must read" for anyone in asbestos litigation.
Lung Cancer Claiming, and the Problem of Fact-Free, Type 1 Commentary on Economic, Social and Legal Issues - Economics and Asbestos
One of the flaws with 24/7 media is endless desire and space for content, and a tendency to publish fact-free articles that masquerade as analysis. That is, articles that typically consists of irrelevant sounds bites that appeal to important but often incorrect type 1 thinking built on reflex instead of analysis of actually relevant facts.
Paul Krugman recently pointed out an example of fact-free commentary in politics and economics by well-known names. In the world of asbestos, otherwise respected commentators Joe Nocera and Paul Brodeur unfortunately joined the parade with fact-free arguments about the merits or demerits of an asbestos lung cancer lawsuit recently filed by a New York legislator who chain smoked for years. Nocera here and Brodeur here.
Both articles toss out useless generalities without actual analysis of the actual facts specific to the specific laws suit. Like Mr. Nocera, I suspect the lawsuit lacks merit but the absence of facts makes my suspicion pointless. It's sad to see respected writers joining in fact-free type 1 thinking instead of actually doing the type 2 research and analysis that made them well known journalists.
One wonders how the litigation industry will evolve in the age of fact-free media dominated by type 1 thinking, made worse by type 1 articles from people who normally undertake type 2 analysis.
Reasons to Invest in Science - So Many Blood Cancers, and New Hope from Great New Science - ASH 2013
(The picture above shows one of two halls used for poster sessions at ASH 2013. The picture is courtesy of Pieter Droppert, who writes about science for investors.)
So many types of blood cancers - the broad classes are myelomas, lymphomas and leukemias.
So many annual blood cancers. The numbers below are provided by the Leukemia and Lymphoma Society and address only the US; the global toll is perhaps incalculable, and almost unspeakable.
- Approximately every 4 minutes one person in the US is diagnosed with a blood cancer
- An estimated combined total of 149,990 people in the US are expected to be diagnosed with leukemia, lymphoma or myeloma in 2013.
- New cases of leukemia, lymphoma and myeloma are expected to account for 9.0 percent of the estimated 1,660,290 new cancer cases diagnosed in the US in 2013.
For Chicagoans looking for wickedly smart humor this weekend, consider singing and dancing lawyers presenting the Chicago Bar Association's annual year end show of musical skits lampooning everybody.
We saw it Wednesday night and it was great, with its theme built around the Wizard of Oz. Our favorite skit of the evening played off the recent Illinois law change to allow gay marriage. The skit was to the tune of "ding, dong, the witch is dead." But in the skit, the lyric instead was "ding, dong, the gays can wed." And the skit was presented as the Oz-like dream/nightmare of Michele Bachmann (Dorothy) after accidentally being hit on the head by a poster carried by supporters of Obamacare.
Another great skit featured a faux Jesse Jackson Jr. singing "Bought It" to the tune of "Beat It." (Non-Chicagoans can go here for the back story if its not news you know.)
So, there's proof - some lawyers really can be creative, and sing and dance too !
Big Tobacco Moves More Massively into the Russian Marketplace - No Fear of Russian Lung Cancer Litigation
Big tobacco continues to expand its global spreading of death and cancer, this time with Phillip Morris and Japan Tobacco making major new investments in Russian tobacco sales. A cynic might think big tobacco does not fear increases in lung cancer litigation in Russia. Besides, even if lung cancer litigation does surge in Russia in 30 years, the profits already will be long gone. And, the potential asbestos defendants there (such as Uralbest) probably will follow the US model of doing very little to force the lung cancer loss onto big tobacco.